ENvue Medical, Inc. Financing Cash Flow
ENvue Medical, Inc. (FEED) reported Financing Cash Flow of $3.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-17
- ENvue Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.59M, a 76.73% decline year-over-year.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $2.34M, a 122.86% increase year-over-year.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$34.00K.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.92M.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $12.79M, a 1278500.00% increase from fiscal 2024.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $1.00K, a 99.98% decline from fiscal 2023.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $4.22M, a 101.82% increase from fiscal 2022.
- ENvue Medical, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $2.09M, a 54.32% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $3.93M 10-Q · filed 2026-08-17 | $3.90M derived: sum of 3 quarters · filed 2026-08-17 | $8.82M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $2.34M 10-Q · filed 2026-05-18 | $2.31M derived: sum of 2 quarters · filed 2026-05-18 | $7.23M derived: sum of 3 quarters · filed 2026-05-18 | $14.08M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $4.89M derived: sum of 2 quarters · filed 2026-04-15 | $11.74M derived: sum of 3 quarters · filed 2026-08-17 | $12.79M 10-K · filed 2026-04-15 |
| 2025-09-30 | $4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $11.77M derived: sum of 2 quarters · filed 2026-08-17 | $12.82M 10-Q · filed 2025-11-14 | $12.82M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $6.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $7.90M 10-Q · filed 2026-08-17 | $7.90M derived: sum of 3 quarters · filed 2026-08-17 | $7.87M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.05M 10-Q · filed 2026-05-18 | $1.05M derived: sum of 2 quarters · filed 2026-05-18 | $1.02M derived: sum of 3 quarters · filed 2026-05-18 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$27.00K derived: sum of 2 quarters · filed 2026-04-15 | $1.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.00K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $28.00K 10-Q · filed 2025-08-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.21M derived: sum of 2 quarters · filed 2025-03-31 | $4.21M derived: sum of 3 quarters · filed 2025-03-31 | $4.22M 10-K · filed 2025-03-31 |
| 2023-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.21M derived: sum of 2 quarters · filed 2024-11-14 | $4.22M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $2.09M 10-K · filed 2024-04-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $3.56M derived: sum of 2 quarters · filed 2023-04-17 | $3.17M derived: sum of 3 quarters · filed 2023-04-17 | $4.58M 10-K · filed 2023-04-17 |
| 2021-09-30 | $3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.17M derived: sum of 2 quarters · filed 2022-11-14 | $4.58M 10-Q · filed 2022-11-14 | $9.84M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$388.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.02M 10-Q · filed 2022-08-15 | $6.28M derived: sum of 3 quarters · filed 2022-08-15 | $10.30M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.41M 10-Q · filed 2022-05-16 | $6.66M derived: sum of 2 quarters · filed 2022-05-16 | $10.69M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $9.28M derived: sum of 2 quarters · filed 2022-04-15 | $9.52M 10-K · filed 2022-04-15 | |
| 2020-09-30 | $4.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.26M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $242.00K 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $1.11M derived: sum of 2 quarters · filed 2021-04-15 | $4.09M derived: sum of 3 quarters · filed 2021-04-15 | $4.32M 10-K · filed 2021-04-15 |
| 2019-09-30 | $1.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $3.98M derived: sum of 2 quarters · filed 2020-11-16 | $4.20M 10-Q · filed 2020-11-16 | $4.25M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $2.98M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-24 | $3.20M 10-Q/A · filed 2020-08-24 | $3.25M derived: sum of 3 quarters · filed 2020-08-24 | $3.27M derived: sum of 4 quarters · filed 2020-08-24 |
| 2019-03-31 | $225.00K 10-Q · filed 2020-07-06 | $275.00K derived: sum of 2 quarters · filed 2020-07-06 | $288.00K derived: sum of 3 quarters · filed 2020-07-06 | |
| 2018-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-20 | $63.00K derived: sum of 2 quarters · filed 2020-05-20 | $94.00K 10-K · filed 2020-05-20 | |
| 2018-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $44.00K 10-Q · filed 2019-11-19 | ||
| 2018-06-30 | $31.00K 10-Q · filed 2019-08-14 | |||
| 2017-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-13 | $5.41M derived: sum of 2 quarters · filed 2019-05-13 | $6.09M derived: sum of 3 quarters · filed 2019-05-13 | $6.44M 10-K · filed 2019-05-13 |
| 2017-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.03M derived: sum of 2 quarters · filed 2018-11-14 | $1.38M 10-Q · filed 2018-11-14 | $1.38M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $680.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.03M 10-Q · filed 2018-08-14 | $1.03M derived: sum of 3 quarters · filed 2018-08-14 | |
| 2017-03-31 | $350.00K 10-Q · filed 2018-05-15 | $350.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $33.00K 10-K · filed 2018-03-29 | ||
| 2016-09-30 | $33.00K 10-Q · filed 2017-11-14 | |||
| 2015-03-31 | $3.00M 10-Q · filed 2015-06-10 | |||
| 2014-03-31 | $100.00K 10-Q · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |